These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure-activity relationships of glucagon-like peptide-1(7-36)amide: insulinotropic activities in perfused rat pancreases, and receptor binding and cyclic AMP production in RINm5F cells. Watanabe Y, Kawai K, Ohashi S, Yokota C, Suzuki S, Yamashita K. J Endocrinol; 1994 Jan; 140(1):45-52. PubMed ID: 8138751 [Abstract] [Full Text] [Related]
3. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas. Suzuki S, Kawai K, Ohashi S, Mukai H, Yamashita K. Endocrinology; 1989 Dec; 125(6):3109-14. PubMed ID: 2684616 [Abstract] [Full Text] [Related]
4. Interaction of glucagon-like peptide-1(7-36)amide and somatostatin-14 in RINm5F cells and in the perfused rat pancreas. Göke R, Fehmann HC, Richter G, Trautmann M, Göke B. Pancreas; 1989 Dec; 4(6):668-73. PubMed ID: 2573056 [Abstract] [Full Text] [Related]
5. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S. Diabetes; 1989 Jul; 38(7):902-5. PubMed ID: 2661287 [Abstract] [Full Text] [Related]
11. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Kawai K, Suzuki S, Ohashi S, Mukai H, Ohmori H, Murayama Y, Yamashita K. Endocrinology; 1989 Apr; 124(4):1768-73. PubMed ID: 2564338 [Abstract] [Full Text] [Related]
17. Stimulatory effects of glucagon-like peptides on human insulinoma cells and insulin-releasing clonal RINm5F cells. Flatt PR, Shiber O, Hampton SM, Marks V. Diabetes Res; 1990 Feb; 13(2):55-9. PubMed ID: 1965428 [Abstract] [Full Text] [Related]
18. N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity. John H, Maronde E, Forssmann WG, Meyer M, Adermann K. Eur J Med Res; 2008 Feb 25; 13(2):73-8. PubMed ID: 18424366 [Abstract] [Full Text] [Related]
19. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells. Fehmann HC, Habener JF. Endocrinology; 1992 May 25; 130(5):2890-6. PubMed ID: 1374016 [Abstract] [Full Text] [Related]